Metraipolis › archive › dc_cd9de406a181

Long-Term Real-World Outcomes of Primary CNS Lymphoma Patients Treated With MATRix Regimen Are Similar to IELSG32 Trial Results — Europe PMC PMID:41108618

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41108618
DOI
10.1002/hon.70142
License (as archived)
solo-consultazione
Archived
2026-11-08T21:06:59.931Z
SHA-256 of the archived text
97d1d410edbc8bf189818bc6d1b3aa53f48b80eb579e7b2b8d069d46202d80bf
Stable URL of this page
https://metraipolis.com/documento/dc_cd9de406a181

How to cite

Long-Term Real-World Outcomes of Primary CNS Lymphoma Patients Treated With MATRix Regimen Are Similar to IELSG32 Trial Results — Europe PMC PMID:41108618 — Europe PMC (en), https://europepmc.org/article/MED/41108618 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd9de406a181 (Metraipolis archive dc_cd9de406a181, sha256 97d1d410edbc8bf189818bc6d1b3aa53f48b80eb579e7b2b8d069d46202d80bf)
BibTeX
@misc{dccd9de406a181,
  title = {Long-Term Real-World Outcomes of Primary CNS Lymphoma Patients Treated With MATRix Regimen Are Similar to IELSG32 Trial Results — Europe PMC PMID:41108618},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41108618},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd9de406a181; sha256 97d1d410edbc8bf189818bc6d1b3aa53f48b80eb579e7b2b8d069d46202d80bf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41108618. Agents can read the archived copy with the MCP tool read_document.